Anti-Arrhythmia Agents
This graph shows the total number of publications written about "Anti-Arrhythmia Agents" by people in the URMC Research Network by year, and whether "Anti-Arrhythmia Agents" was a major or minor topic of these publication.
Below are the most recent publications written about "Anti-Arrhythmia Agents" by people in Profiles.
-
Rajagopalan S, Arora A, Shafiq N, Reddy S S, Pandhi P, Mittal N, Malhotra S. Pharmacotherapy of heart failure with normal ejection fraction (HFNEF)--a systematic review. Br J Clin Pharmacol. 2011 Sep; 72(3):369-80.
-
Patel C, Salahuddin M, Jones A, Patel A, Yan GX, Kowey PR. Atrial fibrillation: pharmacological therapy. Curr Probl Cardiol. 2011 Mar; 36(3):87-120.
-
Logigian EL, Martens WB, Moxley RT, McDermott MP, Dilek N, Wiegner AW, Pearson AT, Barbieri CA, Annis CL, Thornton CA, Moxley RT. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology. 2010 May 4; 74(18):1441-8.
-
Marcus GM, Glidden DV, Polonsky B, Zareba W, Smith LM, Cannom DS, Estes NA, Marcus F, Scheinman MM. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. J Am Coll Cardiol. 2009 Aug 11; 54(7):609-15.
-
Wojtovich AP, Brookes PS. The complex II inhibitor atpenin A5 protects against cardiac ischemia-reperfusion injury via activation of mitochondrial KATP channels. Basic Res Cardiol. 2009 Mar; 104(2):121-9.
-
Giudici MC, Fischer WJ, Cervantes DC, Schrumpf PE, Paul DL, Sentman KE, Serra VL, Barold SS. Ibutilide therapy for atrial fibrillation: 5-year experience in a community hospital. J Cardiovasc Nurs. 2008 Nov-Dec; 23(6):484-8.
-
Couderc JP, Kaab S, Hinterseer M, McNitt S, Xia X, Fossa A, Beckmann BM, Polonsky S, Zareba W. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes. J Clin Pharmacol. 2009 Jan; 49(1):6-16.
-
Couderc JP, Zhou M, Sarapa N, Zareba W. Investigating the effect of sotalol on the repolarization intervals in healthy young individuals. J Electrocardiol. 2008 Nov-Dec; 41(6):595-602.
-
Fossa AA, Wisialowski T, Crimin K, Wolfgang E, Couderc JP, Hinterseer M, Kaab S, Zareba W, Badilini F, Sarapa N. Analyses of dynamic beat-to-beat QT-TQ interval (ECG restitution) changes in humans under normal sinus rhythm and prior to an event of torsades de pointes during QT prolongation caused by sotalol. Ann Noninvasive Electrocardiol. 2007 Oct; 12(4):338-48.
-
Israel CW, Barold SS. Electrical storm in patients with an implanted defibrillator: a matter of definition. Ann Noninvasive Electrocardiol. 2007 Oct; 12(4):375-82.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
